BSECompany Update4d ago · 27 Jul 2026, 06:26 pm

Intimation for Receipt of Request for Reclassification of Shareholder Category

Sun Pharma Advanced Research Company Ltd · 532872

✦ AI SummaryPromoter Reclassif.

Sun Pharma Advanced Research Company Ltd has received requests from two shareholders, Sudhir Vrundavandas Valia and his family members, to reclassify their status from 'Promoter Group' to 'Public' category under SEBI regulations.

Analysis Scores

Earnings Impact0/10
Growth Catalyst0/10
Governance Concern0/10
Regulatory Risk2/10
Balance Sheet Risk0/10
Liquidity Impact0/10
Market Sentiment0/10

✦ Ask a Question

Ask anything about this announcement — AI will answer based on the filing content.

0/500

Full Announcement

Sun Pharma Advanced Research Company Ltd - 532872 - Intimation For Receipt Of Requests For Reclassification Of Shareholder Category

Attachments (1)

📄

4ae0e893-533b-461c-84e3-8f492ed372ae.pdf

pdf

Download →
View document text
SPARC/Sec/SE/2026-27/24 July 27, 2026 National Stock Exchange of India Ltd., BSE Limited, Exchange Plaza, 5th Floor, Market Operations Dept. Plot No. C/1, G Block, P. J. Towers, Bandra Kurla Complex, Dalal Street, Bandra (East), Mumbai – 400 051. Mumbai - 400 001. Scrip Symbol: SPARC Scrip Code: 532872 Dear Sir/Madam, Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015- Receipt of requests for reclassification of shareholder category This is to inform that the Company has received requests on July 27, 2026 from the below- mentioned persons, presently classified as members of the Promoter Group, seeking reclassification of their status from ‘Promoter Group’ category to ‘Public’ category under Regulation 31A of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (“Listing Regulations”): Sr. Name of Shareholder No. of shares held Percentage (%) of No. Shares held 1 Mr. Sudhir Vrundavandas Valia 1 8 , 3 3 , 9 5 1 0 . 5 7 2 Mrs. Raksha Sudhir Valia 41,45,231 1.28 3 Mrs. Krishna Vrundavandas Valia - - Total 59,79,182 1.85 The aforesaid requests will be examined by the Company in accordance with the applicable provisions of the Listing Regulations and shall be placed before the Board of Directors for its consideration in due course. Subject to the approval of the Board and completion of the prescribed process, the Company will take necessary steps, including submission of the application to the stock exchanges. This intimation is being made in compliance with the provisions of the Listing Regulations. For Sun Pharma Advanced Research Company Ltd. Kajal Damania Company Secretary and Compliance Officer